Time in therapeutic range among warfarin users in Turkey: Are there enough data to set definitive criteria for reimbursement?
Guardado en:
Autores principales: | Mehmet Akif Topcuoglu, Ethem Murat Arsava |
---|---|
Formato: | article |
Lenguaje: | EN TR |
Publicado: |
KARE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/df091193f96145bca1bc0815349d320c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Time in therapeutic range values of patients using warfarin and factors that influence time in therapeutic range
por: Lale Dinç Asarcıklı, et al.
Publicado: (2021) -
Long-term follow-up outcomes in a real-world study cohort after percutaneous patent foramen ovale closure
por: Ahmet Hakan Ateş, et al.
Publicado: (2021) -
The association between telomere length and ischemic stroke risk and phenotype
por: Ezgi Yetim, et al.
Publicado: (2021) -
Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)
por: Berkay Ekici, et al.
Publicado: (2021) -
Hyperkalemia in chronic heart failure with renal dysfunction or diabetes mellitus: Results from the TREAT HF study
por: Selda Murat, et al.
Publicado: (2021)